JPRN-UMIN000037765Completed未知
Integrated analysis of genomic and epigenomic alterations in circulating tumor DNA in patients with colorectal cancer and advanced adenoma - COSMOS-CRC-01
ational Cancer Center Hospital East0 sites501 target enrollmentStarted: September 1, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 501
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1.Have previous history of cancer, including colorectal cancer, within 10 years before the enrollment. 2.Have previous history of colorectal advanced adenoma within 3 months before the enrollment. 3.Are suspected to have other malignancies by chest-abdomen-pelvic contrast CT within 60 days before the enrollment. 4.Are pregnant. 5.Are judged by the study doctor to be ineligible for the study for any other reason.
Investigators
Similar Trials
Recruiting
Unknown
Integrated analysis of genomic and epigenomic alterations in circulating tumor DNA in patients with biliary tract cancerBiliary tract cancerJPRN-UMIN000052780ational Cancer Center Hospital East110
Recruiting
Not Applicable
An epigenetic analysis and gene expression profiling on autoimmune gastritis; a multicenter cross-sectional and prospective studyautoimmune gastritisJPRN-UMIN000039528Graduate School of Medicine, The University of Tokyo, Center for Epidemiology and Preventive Medicine50
Completed
Not Applicable
Integrated genomic and epigenomic analysis of blood circulation tumor DNA from gastric cancer and gastric GIST patientsGastric cancer, GISTJPRN-UMIN000040148ational Cancer Center Hospital East600
Completed
Not Applicable
Integrated genomic and epigenomic analysis of blood circulating tumor DNA for pancreatic cancerpancreatic cancerJPRN-UMIN000040470ational Cancer Center Hospital East500
Completed
Not Applicable
Integrated genomic and epigenomic analysis of circulating tumor DNA from patients with malignant melanomaJPRN-UMIN000042040ational Cancer Center Hospital East50